Publication identifier(s): 8702946
A surface coat protein involved in immune evasion in Leishmaniids. Extremely fast evolving, almost completely disordered mucin-like protein. . Localization: Cell surface (experimental)
by homology
Contact email: handman@wehi.edu.au
Publication title: A Leucine-Rich Repeat Motif of Leishmania Parasite Surface Antigen 2 Binds to Macrophages through the Complement Receptor 3
Publication 1st author(s): Kedzierski
Publication Identifier(s): 15067069
Host organism: -1
Interaction detection method(s): fluorescence activated cell sorting
Interaction type: physical association
Identification method participant A: identification by antibody
Identification method participant B: identification by antibody
ID(s) interactor A: P11215
ID(s) interactor B: E9AGG4
Taxid interactor A: Homo sapiens
Taxid interactor B: Leishmania infantum
Biological role(s) interactor A: unspecified role
Biological role(s) interactor B: unspecified role
Experimental role(s) interactor A: unspecified role
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 150 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 7 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 61, no: 10 |
NetGPI | no | yes: 0, no: 71 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 72 |
GO:0042995 | cell projection | 2 | 72 |
GO:0043226 | organelle | 2 | 72 |
GO:0043227 | membrane-bounded organelle | 3 | 72 |
GO:0110165 | cellular anatomical entity | 1 | 72 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 72 |
GO:0016020 | membrane | 2 | 22 |
GO:0005886 | plasma membrane | 3 | 5 |
Related structures:
AlphaFold database: E9AP03
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 3 |
GO:0004672 | protein kinase activity | 3 | 3 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 3 |
GO:0016301 | kinase activity | 4 | 3 |
GO:0016740 | transferase activity | 2 | 3 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 3 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 3 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.775 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.775 |
CLV_PCSK_SKI1_1 | 182 | 186 | PF00082 | 0.604 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.769 |
DEG_SPOP_SBC_1 | 308 | 312 | PF00917 | 0.592 |
DEG_SPOP_SBC_1 | 316 | 320 | PF00917 | 0.576 |
DOC_CYCLIN_yCln2_LP_2 | 10 | 16 | PF00134 | 0.435 |
DOC_MAPK_gen_1 | 276 | 284 | PF00069 | 0.317 |
DOC_MAPK_HePTP_8 | 102 | 114 | PF00069 | 0.251 |
DOC_MAPK_MEF2A_6 | 105 | 114 | PF00069 | 0.249 |
DOC_MAPK_MEF2A_6 | 276 | 284 | PF00069 | 0.451 |
DOC_PP2B_LxvP_1 | 10 | 13 | PF13499 | 0.448 |
DOC_USP7_MATH_1 | 315 | 319 | PF00917 | 0.571 |
DOC_USP7_MATH_1 | 33 | 37 | PF00917 | 0.481 |
DOC_USP7_MATH_1 | 367 | 371 | PF00917 | 0.299 |
DOC_WW_Pin1_4 | 311 | 316 | PF00397 | 0.597 |
DOC_WW_Pin1_4 | 317 | 322 | PF00397 | 0.598 |
LIG_14-3-3_CanoR_1 | 214 | 222 | PF00244 | 0.304 |
LIG_14-3-3_CanoR_1 | 257 | 262 | PF00244 | 0.339 |
LIG_Actin_WH2_2 | 153 | 168 | PF00022 | 0.287 |
LIG_Actin_WH2_2 | 201 | 216 | PF00022 | 0.267 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.678 |
LIG_BRCT_BRCA1_1 | 70 | 74 | PF00533 | 0.457 |
LIG_Clathr_ClatBox_1 | 186 | 190 | PF01394 | 0.301 |
LIG_FHA_1 | 145 | 151 | PF00498 | 0.411 |
LIG_FHA_1 | 44 | 50 | PF00498 | 0.470 |
LIG_FHA_1 | 90 | 96 | PF00498 | 0.371 |
LIG_FHA_2 | 228 | 234 | PF00498 | 0.421 |
LIG_FHA_2 | 281 | 287 | PF00498 | 0.473 |
LIG_FHA_2 | 299 | 305 | PF00498 | 0.588 |
LIG_FHA_2 | 63 | 69 | PF00498 | 0.452 |
LIG_FHA_2 | 92 | 98 | PF00498 | 0.429 |
LIG_LIR_Gen_1 | 128 | 136 | PF02991 | 0.371 |
LIG_LIR_Gen_1 | 249 | 258 | PF02991 | 0.409 |
LIG_LIR_Gen_1 | 71 | 78 | PF02991 | 0.323 |
LIG_LIR_Nem_3 | 103 | 107 | PF02991 | 0.428 |
LIG_LIR_Nem_3 | 128 | 132 | PF02991 | 0.347 |
LIG_LIR_Nem_3 | 192 | 198 | PF02991 | 0.313 |
LIG_LIR_Nem_3 | 238 | 242 | PF02991 | 0.377 |
LIG_LIR_Nem_3 | 71 | 75 | PF02991 | 0.379 |
LIG_PDZ_Class_2 | 386 | 391 | PF00595 | 0.306 |
LIG_PTAP_UEV_1 | 305 | 310 | PF05743 | 0.433 |
LIG_SH2_CRK | 239 | 243 | PF00017 | 0.272 |
LIG_SH2_STAT5 | 239 | 242 | PF00017 | 0.400 |
LIG_SH2_STAT5 | 91 | 94 | PF00017 | 0.292 |
LIG_SH3_3 | 272 | 278 | PF00018 | 0.364 |
LIG_SH3_3 | 303 | 309 | PF00018 | 0.536 |
LIG_SH3_3 | 93 | 99 | PF00018 | 0.437 |
LIG_SUMO_SIM_anti_2 | 106 | 111 | PF11976 | 0.245 |
LIG_SUMO_SIM_anti_2 | 46 | 51 | PF11976 | 0.329 |
LIG_SUMO_SIM_par_1 | 257 | 262 | PF11976 | 0.305 |
LIG_SUMO_SIM_par_1 | 280 | 287 | PF11976 | 0.391 |
LIG_TYR_ITIM | 102 | 107 | PF00017 | 0.478 |
LIG_TYR_ITIM | 237 | 242 | PF00017 | 0.269 |
LIG_UBA3_1 | 135 | 142 | PF00899 | 0.255 |
LIG_UBA3_1 | 186 | 193 | PF00899 | 0.254 |
MOD_CK1_1 | 128 | 134 | PF00069 | 0.395 |
MOD_CK1_1 | 155 | 161 | PF00069 | 0.390 |
MOD_CK1_1 | 203 | 209 | PF00069 | 0.346 |
MOD_CK1_1 | 227 | 233 | PF00069 | 0.379 |
MOD_CK1_1 | 319 | 325 | PF00069 | 0.472 |
MOD_CK1_1 | 36 | 42 | PF00069 | 0.434 |
MOD_CK1_1 | 80 | 86 | PF00069 | 0.424 |
MOD_CK2_1 | 227 | 233 | PF00069 | 0.322 |
MOD_CK2_1 | 298 | 304 | PF00069 | 0.581 |
MOD_CK2_1 | 322 | 328 | PF00069 | 0.423 |
MOD_CK2_1 | 91 | 97 | PF00069 | 0.438 |
MOD_Cter_Amidation | 60 | 63 | PF01082 | 0.479 |
MOD_GlcNHglycan | 114 | 117 | PF01048 | 0.570 |
MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.588 |
MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.501 |
MOD_GlcNHglycan | 218 | 221 | PF01048 | 0.600 |
MOD_GlcNHglycan | 226 | 229 | PF01048 | 0.614 |
MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.615 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.560 |
MOD_GlcNHglycan | 249 | 253 | PF01048 | 0.546 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.774 |
MOD_GlcNHglycan | 261 | 264 | PF01048 | 0.494 |
MOD_GlcNHglycan | 266 | 269 | PF01048 | 0.542 |
MOD_GlcNHglycan | 324 | 327 | PF01048 | 0.669 |
MOD_GlcNHglycan | 338 | 341 | PF01048 | 0.637 |
MOD_GlcNHglycan | 370 | 373 | PF01048 | 0.307 |
MOD_GlcNHglycan | 79 | 82 | PF01048 | 0.580 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.625 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.364 |
MOD_GSK3_1 | 130 | 137 | PF00069 | 0.425 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.425 |
MOD_GSK3_1 | 152 | 159 | PF00069 | 0.444 |
MOD_GSK3_1 | 200 | 207 | PF00069 | 0.379 |
MOD_GSK3_1 | 224 | 231 | PF00069 | 0.366 |
MOD_GSK3_1 | 288 | 295 | PF00069 | 0.429 |
MOD_GSK3_1 | 300 | 307 | PF00069 | 0.546 |
MOD_GSK3_1 | 311 | 318 | PF00069 | 0.541 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.559 |
MOD_GSK3_1 | 350 | 357 | PF00069 | 0.479 |
MOD_GSK3_1 | 64 | 71 | PF00069 | 0.352 |
MOD_GSK3_1 | 73 | 80 | PF00069 | 0.389 |
MOD_N-GLC_1 | 112 | 117 | PF02516 | 0.599 |
MOD_N-GLC_2 | 297 | 299 | PF02516 | 0.718 |
MOD_NEK2_1 | 112 | 117 | PF00069 | 0.360 |
MOD_NEK2_1 | 121 | 126 | PF00069 | 0.375 |
MOD_NEK2_1 | 165 | 170 | PF00069 | 0.444 |
MOD_NEK2_1 | 189 | 194 | PF00069 | 0.359 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.660 |
MOD_NEK2_1 | 213 | 218 | PF00069 | 0.402 |
MOD_NEK2_1 | 298 | 303 | PF00069 | 0.480 |
MOD_OFUCOSY | 70 | 77 | PF10250 | 0.588 |
MOD_PKA_1 | 62 | 68 | PF00069 | 0.312 |
MOD_PKA_2 | 165 | 171 | PF00069 | 0.276 |
MOD_PKA_2 | 213 | 219 | PF00069 | 0.373 |
MOD_Plk_1 | 112 | 118 | PF00069 | 0.394 |
MOD_Plk_1 | 248 | 254 | PF00069 | 0.399 |
MOD_Plk_1 | 354 | 360 | PF00069 | 0.351 |
MOD_Plk_2-3 | 348 | 354 | PF00069 | 0.302 |
MOD_Plk_4 | 131 | 137 | PF00069 | 0.411 |
MOD_Plk_4 | 182 | 188 | PF00069 | 0.379 |
MOD_Plk_4 | 270 | 276 | PF00069 | 0.405 |
MOD_Plk_4 | 45 | 51 | PF00069 | 0.337 |
MOD_Plk_4 | 80 | 86 | PF00069 | 0.376 |
MOD_ProDKin_1 | 311 | 317 | PF00069 | 0.594 |
MOD_ProDKin_1 | 319 | 325 | PF00069 | 0.583 |
MOD_SUMO_rev_2 | 285 | 291 | PF00179 | 0.325 |
MOD_SUMO_rev_2 | 348 | 357 | PF00179 | 0.319 |
MOD_SUMO_rev_2 | 97 | 107 | PF00179 | 0.282 |
TRG_ENDOCYTIC_2 | 104 | 107 | PF00928 | 0.484 |
TRG_ENDOCYTIC_2 | 239 | 242 | PF00928 | 0.389 |
TRG_ER_diArg_1 | 5 | 7 | PF00400 | 0.710 |
TRG_Pf-PMV_PEXEL_1 | 55 | 59 | PF00026 | 0.533 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P227 | Leptomonas seymouri | 31% | 100% |
A0A0N0P2L4 | Leptomonas seymouri | 42% | 100% |
A0A0N1HZ17 | Leptomonas seymouri | 30% | 100% |
A0A0N1I121 | Leptomonas seymouri | 28% | 78% |
A0A0N1I661 | Leptomonas seymouri | 36% | 68% |
A0A0S4IR61 | Bodo saltans | 27% | 97% |
A0A0S4JBV9 | Bodo saltans | 29% | 80% |
A0A0S4JEP2 | Bodo saltans | 22% | 67% |
A0A0S4JS89 | Bodo saltans | 25% | 88% |
A0A0S4JU20 | Bodo saltans | 36% | 100% |
A0A0S4KHE4 | Bodo saltans | 30% | 100% |
A0A0S4KK37 | Bodo saltans | 28% | 67% |
A0A3Q8I9A6 | Leishmania donovani | 67% | 100% |
A0A3Q8I9D0 | Leishmania donovani | 59% | 100% |
A0A3Q8IFC2 | Leishmania donovani | 42% | 90% |
A0A3Q8IIJ9 | Leishmania donovani | 36% | 100% |
A0A3Q8IK15 | Leishmania donovani | 39% | 74% |
A0A3S5H6D6 | Leishmania donovani | 31% | 100% |
A0A3S5H6L9 | Leishmania donovani | 61% | 68% |
A0A3S7WP69 | Leishmania donovani | 25% | 100% |
A0A3S7WPB2 | Leishmania donovani | 24% | 100% |
A0A3S7X4J4 | Leishmania donovani | 36% | 100% |
A4H4D2 | Leishmania braziliensis | 26% | 100% |
A4H4G6 | Leishmania braziliensis | 22% | 100% |
A4H5P0 | Leishmania braziliensis | 25% | 100% |
A4HBX3 | Leishmania braziliensis | 31% | 86% |
A4HJC8 | Leishmania braziliensis | 32% | 100% |
A4HSL2 | Leishmania infantum | 25% | 100% |
A4HTX9 | Leishmania infantum | 31% | 100% |
A4HVB0 | Leishmania infantum | 56% | 97% |
A4I6S2 | Leishmania infantum | 38% | 89% |
A4I6S3 | Leishmania infantum | 43% | 78% |
A4I6S4 | Leishmania infantum | 36% | 100% |
D1GJ51 | Leishmania infantum | 57% | 84% |
E8NHG5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 88% |
E8NHP8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 36% | 100% |
E9ACQ0 | Leishmania major | 24% | 100% |
E9AEF4 | Leishmania major | 43% | 85% |
E9AG65 | Leishmania infantum | 24% | 100% |
E9AGG5 | Leishmania infantum | 63% | 94% |
E9AGG9 | Leishmania infantum | 46% | 72% |
E9AGH0 | Leishmania infantum | 69% | 100% |
E9AKJ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
E9AKM8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 100% |
E9AMQ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E9AP02 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 93% |
E9AP05 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 56% | 76% |
E9AP07 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
E9AP08 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 93% |
E9AVA1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 85% |
E9B1U3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 38% | 86% |
E9B1U4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 100% |
E9B1U5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 93% |
E9B1U6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 37% | 100% |
Q25331 | Leishmania major | 52% | 89% |
Q4PSE6 | Arabidopsis thaliana | 24% | 90% |
Q4Q6B6 | Leishmania major | 35% | 100% |
Q4Q6B7 | Leishmania major | 35% | 100% |
Q4Q6B8 | Leishmania major | 38% | 74% |
Q4QC79 | Leishmania major | 37% | 86% |
Q4QGI0 | Leishmania major | 51% | 77% |
Q4QGI2 | Leishmania major | 48% | 70% |
Q4QGI4 | Leishmania major | 49% | 73% |
Q4QGI6 | Leishmania major | 45% | 71% |
Q4QGJ4 | Leishmania major | 52% | 89% |
Q4QGJ6 | Leishmania major | 54% | 68% |
Q4QGJ7 | Leishmania major | 55% | 89% |
Q4QGJ9 | Leishmania major | 46% | 67% |
Q4QGK0 | Leishmania major | 52% | 69% |
Q4QGK2 | Leishmania major | 50% | 70% |
Q4QGK6 | Leishmania major | 52% | 89% |
Q4QGK8 | Leishmania major | 50% | 76% |
Q4QGL2 | Leishmania major | 50% | 76% |
Q4QGL4 | Leishmania major | 61% | 95% |
Q4QGL5 | Leishmania major | 51% | 71% |
Q4QHW6 | Leishmania major | 28% | 100% |
Q4QJB2 | Leishmania major | 26% | 100% |
Q9LHF1 | Arabidopsis thaliana | 23% | 79% |